These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [New insights in the pathogenesis of pulmonary arterial hypertension]. Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension. Chaumais MC; Guignabert C; Savale L; Jaïs X; Boucly A; Montani D; Simonneau G; Humbert M; Sitbon O Am J Cardiovasc Drugs; 2015 Feb; 15(1):13-26. PubMed ID: 25421754 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719 [TBL] [Abstract][Full Text] [Related]
19. The metabolic theory of pulmonary arterial hypertension. Paulin R; Michelakis ED Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764 [TBL] [Abstract][Full Text] [Related]
20. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females. Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]